Global Hodgkin Lymphoma Treatment Market Segment Research Report 2024
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Hodgkin Lymphoma Treatment Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Hodgkin Lymphoma Treatment industry at home and abroad, estimate the overall market scale of the Hodgkin Lymphoma Treatment industry and the market share of major countries, Hodgkin Lymphoma Treatment industry, and study and judge the downstream market demand of Hodgkin Lymphoma Treatment through systematic research, Analyze the competition pattern of Hodgkin Lymphoma Treatment, so as to help solve the pain points of various stakeholders in Hodgkin Lymphoma Treatment industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Hodgkin Lymphoma Treatment Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Hodgkin Lymphoma Treatment Market?
Cell Medica Limited
Cellular Biomedicine Group, Inc.
Constellation Pharmaceuticals, Inc.
Curis, Inc.
Faron Pharmaceuticals Oy
Fate Therapeutics, Inc.
Gamida Cell Ltd.
Gilead Sciences, Inc.
Incyte Corporation
Merck & Co., Inc.
Mirati Therapeutics Inc.
Molecular Templates Inc.
NantKwest, Inc.
Major Type of Hodgkin Lymphoma Treatment Covered in XYZResearch report
Alocrest
ANK Program
Azacitidine
BMS-986016
BPX-501
Others
Application Segments Covered in XYZResearch Market
Hospital
Clinic
Research Center
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Content
Table of Contents
Global Hodgkin Lymphoma Treatment Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Hodgkin Lymphoma Treatment Market by Value
2.2.1 Global Hodgkin Lymphoma Treatment Revenue by Type
2.2.2 Global Hodgkin Lymphoma Treatment Market by Value (%)
2.3 Global Hodgkin Lymphoma Treatment Market by Production
2.3.1 Global Hodgkin Lymphoma Treatment Production by Type
2.3.2 Global Hodgkin Lymphoma Treatment Market by Production (%)
3. The Major Driver of Hodgkin Lymphoma Treatment Industry
3.1 Historical & Forecast Global Hodgkin Lymphoma Treatment Demand
3.2 Largest Application for Hodgkin Lymphoma Treatment (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Hodgkin Lymphoma Treatment Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Hodgkin Lymphoma Treatment Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Hodgkin Lymphoma Treatment Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Hodgkin Lymphoma Treatment Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Hodgkin Lymphoma Treatment Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Hodgkin Lymphoma Treatment Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Hodgkin Lymphoma Treatment Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Hodgkin Lymphoma Treatment Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Hodgkin Lymphoma Treatment Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Hodgkin Lymphoma Treatment Average Price Trend
12.1 Market Price for Each Type of Hodgkin Lymphoma Treatment in US (2018-2022)
12.2 Market Price for Each Type of Hodgkin Lymphoma Treatment in Europe (2018-2022)
12.3 Market Price for Each Type of Hodgkin Lymphoma Treatment in China (2018-2022)
12.4 Market Price for Each Type of Hodgkin Lymphoma Treatment in Japan (2018-2022)
12.5 Market Price for Each Type of Hodgkin Lymphoma Treatment in India (2018-2022)
12.6 Market Price for Each Type of Hodgkin Lymphoma Treatment in Korea (2018-2022)
12.7 Market Price for Each Type of Hodgkin Lymphoma Treatment in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Hodgkin Lymphoma Treatment Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Hodgkin Lymphoma Treatment
14. Hodgkin Lymphoma Treatment Competitive Landscape
14.1 Cell Medica Limited
14.1.1 Cell Medica Limited Company Profiles
14.1.2 Cell Medica Limited Product Introduction
14.1.3 Cell Medica Limited Hodgkin Lymphoma Treatment Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Cellular Biomedicine Group, Inc.
14.2.1 Cellular Biomedicine Group, Inc. Company Profiles
14.2.2 Cellular Biomedicine Group, Inc. Product Introduction
14.2.3 Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Constellation Pharmaceuticals, Inc.
14.3.1 Constellation Pharmaceuticals, Inc. Company Profiles
14.3.2 Constellation Pharmaceuticals, Inc. Product Introduction
14.3.3 Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Curis, Inc.
14.4.1 Curis, Inc. Company Profiles
14.4.2 Curis, Inc. Product Introduction
14.4.3 Curis, Inc. Hodgkin Lymphoma Treatment Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 Faron Pharmaceuticals Oy
14.5.1 Faron Pharmaceuticals Oy Company Profiles
14.5.2 Faron Pharmaceuticals Oy Product Introduction
14.5.3 Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Fate Therapeutics, Inc.
14.6.1 Fate Therapeutics, Inc. Company Profiles
14.6.2 Fate Therapeutics, Inc. Product Introduction
14.6.3 Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Gamida Cell Ltd.
14.7.1 Gamida Cell Ltd. Company Profiles
14.7.2 Gamida Cell Ltd. Product Introduction
14.7.3 Gamida Cell Ltd. Hodgkin Lymphoma Treatment Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Gilead Sciences, Inc.
14.8.1 Gilead Sciences, Inc. Company Profiles
14.8.2 Gilead Sciences, Inc. Product Introduction
14.8.3 Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Incyte Corporation
14.9.1 Incyte Corporation Company Profiles
14.9.2 Incyte Corporation Product Introduction
14.9.3 Incyte Corporation Hodgkin Lymphoma Treatment Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 Merck & Co., Inc.
14.10.1 Merck & Co., Inc. Company Profiles
14.10.2 Merck & Co., Inc. Product Introduction
14.10.3 Merck & Co., Inc. Hodgkin Lymphoma Treatment Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Mirati Therapeutics Inc.
14.12 Molecular Templates Inc.
14.13 NantKwest, Inc.
15. Conclusion
16. Methodology and Data Source
List of Figure
List of Tables and Figures
Figure 1. Total Demand by Application of Hodgkin Lymphoma Treatment Industry (Volume)
Figure 2. Hodgkin Lymphoma Treatment Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Hodgkin Lymphoma Treatment Revenue in 2022
Figure 5. US Hodgkin Lymphoma Treatment Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Hodgkin Lymphoma Treatment Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Hodgkin Lymphoma Treatment Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Hodgkin Lymphoma Treatment Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Hodgkin Lymphoma Treatment Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Hodgkin Lymphoma Treatment Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Hodgkin Lymphoma Treatment Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Hodgkin Lymphoma Treatment Revenue, by Type (Million USD) (2018-2028)
Table 4. Hodgkin Lymphoma Treatment Production, by Type (K Unit) (2018-2028)
Table 5. Hodgkin Lymphoma Treatment Demand (K Unit) by Application (2018-2028)
Table 6. Hodgkin Lymphoma Treatment Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Hodgkin Lymphoma Treatment Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Hodgkin Lymphoma Treatment Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Hodgkin Lymphoma Treatment Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Hodgkin Lymphoma Treatment Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Hodgkin Lymphoma Treatment Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Hodgkin Lymphoma Treatment Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Hodgkin Lymphoma Treatment Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Hodgkin Lymphoma Treatment Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Hodgkin Lymphoma Treatment in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Hodgkin Lymphoma Treatment in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Hodgkin Lymphoma Treatment in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Hodgkin Lymphoma Treatment in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Hodgkin Lymphoma Treatment in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Hodgkin Lymphoma Treatment in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Hodgkin Lymphoma Treatment in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Cell Medica Limited Profiles
Table 61. Cell Medica Limited Hodgkin Lymphoma Treatment Product Introduction
Table 62. Cell Medica Limited Hodgkin Lymphoma Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Cell Medica Limited Strategic initiatives
Table 64. Cellular Biomedicine Group, Inc. Profiles
Table 65. Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Product Introduction
Table 66. Cellular Biomedicine Group, Inc. Hodgkin Lymphoma Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Cellular Biomedicine Group, Inc. Strategic initiatives
Table 68. Constellation Pharmaceuticals, Inc. Profiles
Table 69. Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Product Introduction
Table 70. Constellation Pharmaceuticals, Inc. Hodgkin Lymphoma Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Constellation Pharmaceuticals, Inc. Strategic initiatives
Table 72. Curis, Inc. Profiles
Table 73. Curis, Inc. Hodgkin Lymphoma Treatment Product Introduction
Table 74. Curis, Inc. Hodgkin Lymphoma Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Curis, Inc. Strategic initiatives
Table 76. Faron Pharmaceuticals Oy Profiles
Table 77. Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Product Introduction
Table 78. Faron Pharmaceuticals Oy Hodgkin Lymphoma Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. Faron Pharmaceuticals Oy Strategic initiatives
Table 80. Fate Therapeutics, Inc. Profiles
Table 81. Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Product Introduction
Table 82. Fate Therapeutics, Inc. Hodgkin Lymphoma Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Fate Therapeutics, Inc. Strategic initiatives
Table 84. Gamida Cell Ltd. Profiles
Table 85. Gamida Cell Ltd. Hodgkin Lymphoma Treatment Product Introduction
Table 86. Gamida Cell Ltd. Hodgkin Lymphoma Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. Gamida Cell Ltd. Strategic initiatives
Table 88. Gilead Sciences, Inc. Profiles
Table 89. Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Product Introduction
Table 90. Gilead Sciences, Inc. Hodgkin Lymphoma Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Gilead Sciences, Inc. Strategic initiatives
Table 92. Incyte Corporation Profiles
Table 93. Incyte Corporation Hodgkin Lymphoma Treatment Product Introduction
Table 94. Incyte Corporation Hodgkin Lymphoma Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Incyte Corporation Strategic initiatives
Table 97. Merck & Co., Inc. Profiles
Table 98. Merck & Co., Inc. Hodgkin Lymphoma Treatment Product Introduction
Table 99. Merck & Co., Inc. Hodgkin Lymphoma Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. Merck & Co., Inc. Strategic initiatives
Table 101. Mirati Therapeutics Inc. Profiles
Table 102. Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Product Introduction
Table 103. Mirati Therapeutics Inc. Hodgkin Lymphoma Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Mirati Therapeutics Inc. Strategic initiatives
Table 105. Molecular Templates Inc. Profiles
Table 106. Molecular Templates Inc. Hodgkin Lymphoma Treatment Product Introduction
Table 107. Molecular Templates Inc. Hodgkin Lymphoma Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Molecular Templates Inc. Strategic initiatives
Table 109. NantKwest, Inc. Profiles
Table 110. NantKwest, Inc. Hodgkin Lymphoma Treatment Product Introduction
Table 111. NantKwest, Inc. Hodgkin Lymphoma Treatment Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. NantKwest, Inc. Strategic initiatives
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices